Get insight from foundation experts on research, treatment and prevention, plus the very latest news and events.
Switch on your HIV smarts.
Low bone mineral density is common among people living with HIV and puts individuals at increased risk for fractures. Supplementation with calcium and vitamin D, both known to benefit bone … Read More
Hepatitis C was a major theme at the 21st Conference on Retroviruses and Opportunistic Infections this week in Boston. While development of new HIV drugs has slowed in recent years, hepatitis … Read More
To date, the only product currently approved for pre-exposure prophylaxis (PrEP) is Truvada, a combination of the drugs tenofovir (brand name Viread) and emtricitibine (Emtriva). While Truvada PrEP is highly … Read More
Join us for daily news and commentary on HIV/AIDS treatment, prevention and policy.
The foundation's ongoing forum series bringing research and evidence to bear on timely policy and programmatic issues.